Egg freezing: Britain’s largest ever study reports live birth outcomes comparable to those of routine IVF

(Press-News.org) 18 July 2024: Britain’s largest ever study of egg freezing which followed up the outcome of almost 30,000 eggs frozen at the London Women’s Clinic shows that success rates are comparable to those achieved by routine IVF and subject to the same variables of female age and embryo quality.(1) When seen alongside other similar large-scale egg-freezing studies from other countries, the results of this study add to a pattern of success which is consistent, predictable and reliable.

The study, published today in the peer-reviewed journal Reproductive Biomedicine Online, analysed the outcomes of treatment for 299 patients who had frozen their eggs between 2008 and 2022 and returned to thaw them for fertilisation and pregnancy. The results of this 15-year study found an overall live birth rate per embryo transfer of 26% which varied according to the age at which the eggs were frozen, with a lower rate in over-35s but only 5% in over-40s.

The cumulative live birth rate after the transfer of all embryos created from the thawed eggs was 34%, rising to 45% in those who had frozen their eggs before the age of 36.

‘These are results comparable with those nationally recorded in routine IVF,’ said Professor Nick Macklon, senior author of the study and Medical Director of the London Women’s Clinic. ‘The results are also comparable with those reported from other similar studies in the USA, suggesting that the doubts still commonly expressed about the reliability of egg freezing are misplaced. Taken together, the results appear consistent, predictable and reassuring.’(2)

What has this and other studies told us so far:

The number of women seeking egg-freezing treatment for personal reasons is increasing; in this single-centre study annual patient numbers rose from 150 women in 2015 to more than 800 in 2022.
  However, the number of women returning to thaw their frozen eggs remains quite low and steady; only 299 of 2171 patients freezing their eggs returned and completed 332 thaw treatment cycles. Thus, the return rate was 14%, a rate similar to that found in other studies.
  Overall, around one quarter of those who fertilised their thawed eggs and transferred them as ‘fresh’ embryos had a baby; the overall cumulative live birth rate, calculated from further frozen embryo transfers was 36% (and 57% in patients who had stored their eggs when aged under 35).
  When all eggs were thawed, fertilised and embryos frozen (‘freeze-all’), live birth rate reached 30% for each frozen/thawed embryo transfer.
  The success rate in freeze-all cycles was considerably improved for those who chose to have their embryos screened for chromosome abnormalities (PGT-A). Indeed, across all ages the use of PGT-A was associated with a live birth rate double that found with freeze-all treatments with an untested embryo (40% vs 21%). Indeed, all live births in women aged 40 or over were from an embryo which had been screened as chromosomally normal.
  The mean age at which the ‘thaw’ patients froze their eggs was 37.6 years; the age at which they returned to thaw and use their eggs was 40 years with an overall average storage period of 24 months.
‘These are encouraging results for those considering freezing their eggs for future use,’ said Professor Macklon. ‘Current consensus based on these and other results would be that 10 to 15% of patients who originally froze their eggs in their later thirties will return to thaw and use them when they are, on average, between 40 and 42 years old.’

The results also challenge the sceptical perception of egg freezing, which may arise from dated studies. The UK regulator, the Human Fertilisation and Embryology Authority (HFEA), for example, recently warned that ‘when looking at success rates for frozen eggs, numbers tend to be quite low’. However, the results from this large study reflect outcomes which are robustly recorded and analysed, and comparable with those of fresh single embryo transfers in IVF when age and egg quality and quantity are taken into account.

‘It thus seems reasonable to conclude,’ said Professor Macklon, ‘that based on these results and those of other studies egg freezing and thawing can provide a very real opportunity for women to achieve pregnancy and live birth at a time of their choosing. With consistency in results, patient expectations can be managed similarly to all IVF treatments. An assessment of age and embryo quality can help estimate the potential outcomes of treatment.’

Notes

Shah T, Garratt J, Mclaughlin A, et al. Clinical outcomes of vitrified-warmed autologous oocyte cycles with 15-year follow-up at a single UK centre: consistent and predictable results. Reprod Biomed Online 2024; https://doi.org/10.1016/j.rbmo.2024.104376
  For comparative purposes, the results of this study were analysed alongside two others:
- Blakemore JK, Grifo JA, DeVore SM, et al. Planned oocyte cryopreservation - 10-15-year follow-up: return rates and cycle outcomes. Fertil Steril 2021; 115: 1511–1520. https://doi.org/10.1016/j.fertnstert.2021.01.011
- Kawwass JF, Crawford S, Hipp HS. Frozen eggs: national autologous oocyte thaw outcomes. Fertil Steril 2021; 116: 1077–1084. https://doi.org/10.1016/J.FERTNSTERT.2021.05.080
  National statistics from the UK, as reported by the HFEA, describe egg and embryo storage cycles as ‘the fastest growing fertility treatments in the UK’, adding that egg freezing treatments increased from 373 cycles in 2011 to 4215 cycles in 2021. The technique has been facilitated by improvements in freezing technology and the uptake of fast-freezing vitrification. Ice crystal formation in earlier slow-freezing methods was found to cause damage to cells; survival rates from vitrified/thawed have been found above 90% in recent studies. Studies suggest there are two principal reasons for egg freezing: to preserve fertility ahead of toxic treatment such as chemotherapy; and electively to postpone the opportunity for pregnancy to a later date
  * RBM Online, founded by Professor Sir Robert Edwards in 2000, is a monthly peer-reviewed journal covering the full range of human reproductive health and disease, including basic and translational science, embryology, ART, infertility, male reproduction, periconception and pregnancy, reproductive health and the social implications of fertility care.

* For more information on this press release and the published paper, please contact:
Duncan Nicholas, RBM Online Development Editor
dev.editor@rbmonline.com
https://linktr.ee/rbmo

 

END